SINGLETTO

We develop photodynamic therapies (PDT) that use singlet oxygen to destroy COVID-19 and other pathogens. Singletto is founded by Tom Lendvay, James Chen, and John Bjornson... The interaction between light, certain colored molecules, and oxygen can create singlet oxygen. Singlet oxygen is well known for its ability to inactivate harmful pathogens. Singletto's team of chemistry and virology experts specialize in the optimization of light and color to create effective, safe, pathogen-killing singlet oxygen solutions. Meet Singletto's expert team…... Singletto's technology is simple and proven, but innovation drives us. Singletto's partner labs and expert chemists, virologists, and researchers continue research and development. We're optimizing technology for specific use cases, environments, and consumer needs. We're partnering with trusted brands to create everyday products with this pathogen-fighting technology. A partnership with Singletto means an investment in ongoing R&D. Partner..

Also known as: Singletto Labs, Singletto, Inc